EFFICACY AND SAFETY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: 12 MONTH RESULTS OF A PHASE III, RANDOMIZED, CONTROLLED STUDY

被引：0

作者：

Saliba, Faouzi ^{[1
]}

De Simone, Paolo ^{[2
]}

Nevens, Frederik ^{[3
]}

De Carlis, Luciano ^{[4
]}

Metselaar, Herold ^{[5
]}

Beckebaum, Susanne ^{[6
]}

Jonas, Sven ^{[7
]}

Sudan, Debra ^{[8
]}

Fischer, Lutz ^{[9
]}

Fung, John J. ^{[10
]}

Jiang, Hai ^{[11
]}

Junge, Guido ^{[12
]}

机构：

[1] Hop Paul Brousse, Hepatobiliary Ctr, Villejuif, France

[2] Azienda Osped Univ Pisana, Pisa, Italy

[3] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium

[4] Osped Niguarda Ca Granda, Milan, Italy

[5] Univ Hosp Rotterdam, Erasmus MC, Rotterdam, Netherlands

[6] Univ Hosp Essen, Essen, Germany

[7] Univ Med Ctr Leipzig, Leipzig, Germany

[8] Duke Univ, Med Ctr, Durham, NC USA

[9] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany

[10] Cleveland Clin Fdn, Cleveland, OH 44195 USA

[11] Novartis Pharmaceut, E Hanover, NJ USA

[12] Novartis Pharma AG, Basel, Switzerland

来源：

HEPATOLOGY | 2011年 / 54卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1430A / 1431A

页数：2

共 50 条

[31] Efficacy and Safety of Everolimus with Reduced Tacrolimus or Cyclosporine in Pediatric Liver Transplant Recipients: 12-Month Results from H2305 Study [J].

Weymann, A. ;

Ganschow, R. ;

Ericzon, B. ;

Dhawan, A. ;

Sharif, K. ;

Martzloff, E. -D. ;

Rauer, B. ;

Ng, J. ;

Lopez, P. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 :234-234

[32] Improvement of renal function with everolimus plus reduced tacrolimus in de novo liver transplant recipients - HEPHAISTOS study 12 month data. [J].

Schlitt, H. J. ;

Nashan, B. ;

Braun, F. ;

Pascher, A. ;

Klein, C. -G ;

Neumann, U. ;

Kroeger, I ;

Wimmer, P. ;

Schemmer, P. .

TRANSPLANTATION, 2019, 103 (08) :46-46

[33] Everolimus (Certican) 12-month safety and efficacy versus mycophenolate mofetil in de novo renal transplant recipients [J].

Vitko, S ;

Margreiter, R ;

Weimar, W ;

Dantal, J ;

Viljoen, HG ;

Li, YL ;

Jappe, A ;

Cretin, N .

TRANSPLANTATION, 2004, 78 (10) :1532-1540

[34] EARLY EVEROLIMUS-BASED TACROLIMUS REDUCTION IN DE NOVO LIVER TRANSPLANT RECIPIENTS: DESIGN AND BASELINE DATA FROM HEPHAISTOS STUDY [J].

Nashan, B. ;

Schemmer, P. ;

Braun, F. ;

Dworak, M. ;

Wimmer, P. ;

Schlitt, H. .

JOURNAL OF HEPATOLOGY, 2015, 62 :S850-S850

[35] Safety of Early Everolimus in De Novo Heart Transplant Recipients: Interim Analysis of the Randomized Study EVERHEART [J].

Potena, L. ;

Barberini, F. ;

Boffini, M. ;

Amarelli, C. ;

Pellegrini, C. ;

Livi, U. ;

Masciocco, G. ;

Faggian, G. ;

Gerosa, G. ;

Lilla, P. ;

Marraudino, N. ;

Porcu, M. ;

Guarisco, R. ;

Maccherini, M. .

JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04) :S136-S136

[36] Delayed Introduction of Everolimus Versus Tacrolimus in de Novo Liver Transplant Recipients: Safety Events of Interest with Everolimus Use [J].

Fischer, L. ;

Chavin, K. ;

Huang, M. A. ;

Kozlowski, T. ;

Dong, G. ;

Lopez, P. ;

Junge, G. ;

De Carlis, L. .

TRANSPLANTATION, 2012, 94 (10) :48-48

[37] Efficacy and safety of everolimus with reduced tacrolimus in living-donor liver transplant recipients: 12-month results of a randomized multicenter study (vol 18, pg 1435, 2018) [J].

Jeng, L-B .

AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 (10) :2489-2490

[38] EVEROLIMUS-BASED IMMUNOSUPPRESSION IN HCV POSITIVE DE NOVO LIVER TRANSPLANT RECIPIENTS: 24-MONTH RESULTS OF A RANDOMIZED CONTROLLED TRIAL [J].

Saliba, F. ;

Metselaar, H. J. ;

Beckebaum, S. ;

Duvoux, C. ;

Navasa, M. ;

Dong, G. ;

Lopez, P. ;

Nevens, F. .

JOURNAL OF HEPATOLOGY, 2013, 58 :S79-S80

[39] Hephaistos Study Outcome on Renal Function after 12 Month Everolimus Plus Reduced Tacrolimus in De Novo Liver Transplant Recipients versus Standard Tacrolimus. [J].

Braun, F. ;

Schemmer, P. ;

Schlitt, H. ;

Pascher, A. ;

Klein, C. ;

Neumann, U. ;

Kroeger, I. ;

Wimmer, P. ;

Nashan, B. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 :556-556

[40] Efficacy and Safety of Everolimus With Reduced Tacrolimus Compared to Standard Tacrolimus in Recipients of Living Donor Liver Transplant: Design of a Randomized Study [J].

Grant, D. ;

Levy, G. ;

Song, G. ;

Chen, C. ;

Lee, W. ;

Joh, J. ;

Speziale, A. ;

Rauer, B. ;

Wang, Z. ;

Junge, G. ;

Uemoto, S. ;

Suh, K. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 :781-782

← 1 2 3 4 5 →